Actavis produces and markets generic pharmaceutical products for human use, covering all significant therapeutic classes.

Together with tablets and capsules, the company also produces injectables, parenterals, suspensions, suppositories, creams and ointments.

Actavis has established itself as a reliable source of pharmaceutical intellectual property, sold via its export division, Medis.

Furthermore, the group manufactures a range of active pharmaceutical ingredients, principally for the European and US export markets.

The quality of Actavis’ products is one of the company’s key considerations. Regulatory compliance and GMP (Good Manufacturing Practices) are constant considerations in all its production. Fast development, quality, economies of scale and reliability are the cornerstones of Actavis's product range.